Mohamad Sawan

Mohamad Sawan

Mohamad Sawan (S’88–M’89–SM’96– F’04) received his PhD degree in electrical engineering from Université de Sherbrooke, Sherbrooke, Québec, Canada. He joined École Polytechnique de Montréal in 1991, where he is currently Professor of microelectronics and biomedical engineering. His interests encompass the design and testing of analog, digital, Radio Frequency and optic circuits and microsystems. Dr. Sawan was awarded the Canada Research Chair in Smart Medical Devices (2001- 2015). He leads the Microsystems Strategic Alliance of Quebec and is Founder of the Polystim Neurotechnologies Laboratory. Dr. Sawan is Founder and Co-founder of several international conferences, such as IEEE, NEWCAS, ICECS, and BIOCAS. He is Co-founder and Editor-in-Chief of IEEE Transactions on BioCAS, Deputy Editor-in Chief of IEEE TCAS-II (2009-2013), Associate Editor of IEEE Transactions on Biomedical Engineering, and Editor, Associate Editor and member of the Editorial Board of several other international journals. Dr. Sawan is Founder and Chair of the Eastern Canadian IEEE-Solid State Circuits Society Chapter. He has published more than 700 peer-reviewed papers, 2 books, 10 book chapters, and 12 patents. Dr. Sawan has received several distinctions, among them the Shanghai Municipality International Collaboration Award, the Queen Elizabeth II Golden Jubilee Medal, the Bombardier Medal for Technology Transfer, the Jacques-Rousseau Award for achieved results in multidisciplinary research activities, and the Barbara Turnbull Award for Spinal Cord Research in Canada. He is Fellow of the IEEE, Fellow of the Canadian Academy of Engineering, Fellow of the Engineering Institute of Canada, and Officer of the Order of Québec.


  • CMOS Based Smart Petridish: A Paradigm Shift in Drug Testing Technology
    Smart Cell Culture Monitoring and Drug Test Platform Using CMOS Capacitive Sensor Array

    Integrated Microfluidic CMOS or imCMOS has recently received significant interest, as a new paradigm in the design and implementation of chemical/biological analysis platforms, for life science applications. Among these applications, this research has focused on developing a novel imCMOS device for monitoring drug cytotoxicity. This device incorporated with polyelectrolyte layers consists of 8×8 capacitive sensors integrated on the same chip. With the potential to perform label free cellular analysis, the proposed platform opens an avenue to transit from traditional to smart cellular analysis techniques suitable for a variety of biological applications, in particular high throughput cell based drug testing.

  • A Functional-genetic Scheme for Seizure Forecasting in Canine Epilepsy
    A Functional-genetic Scheme for Seizure Forecasting in Canine Epilepsy

    Seizure prediction is currently a major concern in the epilepsy research community. In this work, we have proposed a new strategy to achieve accurate seizure forecasting by combining effective connectivity measures and artificial intelligence techniques. Results show performance improvement compared to previous studies, achieving average sensitivity of 84.82% and time in warning of 0.1.


New Here? Sign Up

Looking for increased exposure in the field of biomedical engineering? EMBS offers journals, conferences and a community for biomedical engineers. Membership includes PULSE Magazine.